butorphanol has been researched along with Cancer of Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, P; Hai, L; Hu, Q; Nie, X; Wang, J; Zhao, Q | 1 |
1 other study(ies) available for butorphanol and Cancer of Liver
| Article | Year |
|---|---|
Butorphanol inhibits angiogenesis and migration of hepatocellular carcinoma and regulates MAPK pathway.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Butorphanol; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Liver Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic | 2022 |